Literature DB >> 9316420

Genistein potentiates wild-type and delta F508-CFTR channel activity.

T C Hwang1, F Wang, I C Yang, W W Reenstra.   

Abstract

Effects of genistein on wild-type (wt) and delta F508-cystic fibrosis transmembrane conductance regulator (CFTR) were studied in NIH/3T3 cells stably transfected with wt or mutant CFTR cDNA. As measured by I- efflux, half-maximal concentration of agonist (K1/2) for forskolin-dependent activation was greater for delta F508-CFTR than wt-CFTR. Genistein decreased the K1/2 for both forms of the channel and increased the maximal activity of delta F508-CFTR by 3.7-fold. In cell-attached patches, 10 microM forskolin induced minimal delta F508-CFTR activity with characteristic prolonged closed times (estimated time constant, > 30 s). Genistein increased the forskolin-induced macroscopic currents of wt-CFTR and delta F508-CFTR by 3- and 19-fold, respectively. Variance analysis suggested that in the presence of forskolin and genistein the open probabilities (Po) of wt- and delta F508-CFTR were identical. In single-channel studies, at maximal adenosine 3',5'-cyclic monophosphate (cAMP) stimulation, genistein increased the Po of wt-CFTR by prolonging the open time, but, at submaximal cAMP stimulation, the Po was increased by prolonging the open time and shortening the closed time. In excised patches with CFTR channels preactivated in the cell-attached mode, genistein increased ATP-dependent wt- and delta F508-CFTR current about twofold by prolonging the open time. Our results thus suggest that phosphorylation-dependent activation of delta F508-CFTR is defective and that genistein corrects this defect at least in part by binding to the CFTR protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316420     DOI: 10.1152/ajpcell.1997.273.3.C988

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  62 in total

Review 1.  Novel pharmacologic therapies for cystic fibrosis.

Authors:  P L Zeitlin
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.

Authors:  C Randak; E A Auerswald; I Assfalg-Machleidt; W W Reenstra; W Machleidt
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

Authors:  Xuehong Liu; Nicolette O'Donnell; Allison Landstrom; William R Skach; David C Dawson
Journal:  Biochemistry       Date:  2012-06-15       Impact factor: 3.162

4.  CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity.

Authors:  Stefania Monterisi; Maria Favia; Lorenzo Guerra; Rosa A Cardone; Domenico Marzulli; Stephan J Reshkin; Valeria Casavola; Manuela Zaccolo
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

5.  Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening.

Authors:  Ori Kalid; Martin Mense; Sharon Fischman; Alina Shitrit; Hermann Bihler; Efrat Ben-Zeev; Nili Schutz; Nicoletta Pedemonte; Philip J Thomas; Robert J Bridges; Diana R Wetmore; Yael Marantz; Hanoch Senderowitz
Journal:  J Comput Aided Mol Des       Date:  2010-10-26       Impact factor: 3.686

6.  Assessment of CFTR chloride channel openers in intact normal and cystic fibrosis murine epithelia.

Authors:  A W Cuthbert
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

7.  A posttranslational modification code for CFTR maturation is altered in cystic fibrosis.

Authors:  Sandra Pankow; Casimir Bamberger; John R Yates
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

Review 8.  Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.

Authors:  James L Kreindler
Journal:  Pharmacol Ther       Date:  2009-11-10       Impact factor: 12.310

9.  Direct effects of 9-anthracene compounds on cystic fibrosis transmembrane conductance regulator gating.

Authors:  Tomohiko Ai; Silvia G Bompadre; Yoshiro Sohma; Xiaohui Wang; Min Li; Tzyh-Chang Hwang
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

10.  Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle.

Authors:  Kang-Yang Jih; Tzyh-Chang Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.